-
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
PRNewswire
January 15, 2025
Samsung Biologics (KRX: 207940.KS) announced its latest business achievements and 2025 outlook at the 43rd J.P. Morgan Healthcare Conference, which was held in San Francisco between January 13-16.
-
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
PRNewswire
January 09, 2025
Samsung Biologics (KRX: 207940.KS) announced to extend collaboration with LigaChem Biosciences (KOSDAQ: 141080) to provide antibody-drug conjugate (ADC) services.
-
Immuno-Oncology: Current Market Landscape and Future Trends（2）
Neeta Ratanghayra
September 18, 2024
CAR-T Therapy & Antibody–Drug Conjugates.
-
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
PharmaSources.com
February 18, 2022
The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing...
-
Piramal spends £55m to bolster its UK manufacturing presence
CPhIonline
February 10, 2022
The investment covers two expansions to accommodate several pipeline products moving to commercial scale.
-
Piramal Pharma Solutions Expands & Upgrades UK Facilities
contractpharma
February 08, 2022
£55 million investment includes a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth and enhanced API manufacturing in Morpeth.
-
Mersana, Janssen Biotech partner to discover new ADC product candidates
pharmaceutical-business-review
February 04, 2022
Mersana Therapeutics and Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have entered into a research...
-
CuriRx Launches the Advanced Bioprocessing and Analytical Center
contractpharma
January 26, 2022
New center allows the CDMO to further support biotherapeutic drug developers.
-
CStone Pharmaceuticals announced the IND approval of CS5001, a potential global best-in-class ROR1-targeting ADC by the U.S. Food and Drug Administration
prnasia
January 04, 2022
CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies...
-
Genmab Gains Broad Access to Synaffix's ADC Technologies
contractpharma
January 04, 2022
Secures rights for conducting research on ADCs against multiple drug targets under new licensing agreement.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
